Loading...
Fidaxomicin Therapy in Critically Ill Patients with Clostridium difficile Infection
Fidaxomicin use to treat proven Clostridium difficile infection (CDI) was compared between 20 patients receiving care in critical care units (CCUs) and 30 patients treated on general medical floors. At baseline, the CCU patients had more initial CDI episodes, more severe and complicated disease, and...
Na minha lista:
| Udgivet i: | Antimicrob Agents Chemother |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4325788/ https://ncbi.nlm.nih.gov/pubmed/25534722 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.04268-14 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|